Mukka Proteins
Ticker > Company >

Mukka Proteins share price

Mukka Proteins Ltd.

NSE: MUKKA BSE: 544135 SECTOR: Consumer Food  67k   94   10

40.62
-0.87 (-2.10%)
BSE: 21 Nov 04:00 PM

Price Summary

Today's High

₹ 42.45

Today's Low

₹ 40.25

52 Week High

₹ 56.52

52 Week Low

₹ 30

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1218.6 Cr.

Enterprise Value

₹ 1387.37 Cr.

No. of Shares

30 Cr.

P/E

27.73

P/B

3.06

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  13.3

CASH

₹ 13.89 Cr.

DEBT

₹ 182.66 Cr.

Promoter Holding

73.33 %

EPS (TTM)

₹  1.47

Sales Growth

0

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.22%
3 Year31.71%
5 Year27.55%

Profit Growth

1 Year56.35%
3 Year88.98%
5 Year40.27%

ROE%

1 Year27.32%
3 Year32.42%
5 Year28.43%

ROCE %

1 Year19.39%
3 Year20.73%
5 Year17.97%

Debt/Equity

0.9146

Price to Cash Flow

286.66

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.33 0.00
Jun 2024 73.33 0.00
Mar 2024 73.33 0.00
Dec 2023 73.33 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 23.5778186316143% for the Past 3 years.
  • The company has shown a good revenue growth of 31.7148390037495% for the Past 3 years.
  • Company has been maintaining healthy ROE of 32.4171151364639% over the past 3 years.
  • Company has been maintaining healthy ROCE of 20.7269477556598% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a high promoter holding of 73.33%.

 Limitations

  • Company has low Interest coverage ratio of 0.
  • Company has negative cash flow from operations of -150.408.
  • Tax rate is low at 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 516.99 256.7 172.5 149.19
Total Expenditure 498.11 224.51 158.37 139.63
Operating Profit 18.88 32.19 14.13 9.57
Other Income 6.18 3.28 2.85 3.14
Interest 6.15 6.63 8.13 8.72
Depreciation 3.18 3.34 3.12 3.76
Exceptional Items 0 0 0 0
Profit Before Tax 15.73 25.5 5.73 0.23
Tax 5.4 -2.2 0.28 -0.42
Profit After Tax 10.33 27.7 5.45 0.65
Adjustments 0.14 -0.53 -1.22 1.44
Consolidated Net Profit 10.47 27.17 4.23 2.08
Adjusted EPS (Rs) 0.48 0.91 0.14 0.07

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 549.25 603.83 770.5 1177.12 1379.83
Total Expenditure 525.46 581.95 723.72 1090.95 1274.36
Operating Profit 23.79 21.88 46.78 86.17 105.47
Other Income 7.84 9.94 7.46 6.68 16.32
Interest 7.21 8.02 9.68 16.48 25.1
Depreciation 4.69 8.34 8.58 11.89 12.34
Exceptional Items 0 0 0 0 0
Profit Before Tax 19.73 15.46 35.98 65.94 87.46
Tax 6.16 4.45 10.16 18.42 13.15
Profit After Tax 13.57 11.01 25.82 47.53 74.31
Adjustments -0.4 -2.03 -1.61 -3.45 -4.25
Consolidated Net Profit 13.18 8.98 24.21 44.08 70.05
Adjusted EPS (Rs.) 0.6 0.41 1.1 2 2.34

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 5.5 5.5 22 22 30
Total Reserves 51.05 61.02 76.37 125.8 366.09
Minority Interest 1.2 3.4 4.71 8.04 12.22
Borrowings 13.93 8.97 9.37 5.36 6.39
Other N/C liabilities 3.94 3.67 5.93 11.16 5.17
Current liabilities 217.49 272.23 273.92 402.8 520.93
Total Liabilities 293.12 354.8 392.3 575.16 940.79
Assets
Net Block 76.93 77.58 81.27 83.43 83.59
Capital WIP 2.19 4.03 0 0 0
Intangible WIP 0 0 0 0 0
Investments 4.96 11.75 20.53 21.34 31.1
Loans & Advances 2.72 2.63 2.72 4.78 8.11
Other N/C Assets 0 1.42 1.4 1.57 1.48
Current Assets 206.32 257.38 286.39 464.04 816.52
Total Assets 293.12 354.8 392.3 575.16 940.79
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 19.73 15.46 35.98 65.94 87.46
Adjustment 6.31 9.56 11.12 16.94 21.84
Changes in Assets & Liabilities -45.21 -18.64 -36.54 -128.08 -233.68
Tax Paid -5.9 -4.59 -5.69 -11.13 -26.03
Operating Cash Flow -25.07 1.79 4.87 -56.33 -150.41
Investing Cash Flow -27.97 -13.61 -11.48 -3.32 -47.59
Financing Cash Flow 53.78 13.48 14.99 74.67 262.59
Net Cash Flow 0.74 1.66 8.38 15.01 64.59

Corporate Actions

Investors Details

PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 73.33 73.33 73.33 73.33
k mohammad arif 16.13 16.13 16.13 16.13
k mohammed althaf 16.13 16.13 16.13 16.13
kalandan abdul razak 7.33 7.33 7.33 7.33
mohammed haris k 30.23 30.23 30.23 30.23
umaiyya banu 3.50 3.50 3.50 3.50
PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 26.67 26.67 26.67 26.67
craft emerging market fun... 1.22 1.22 1.19 1.19
llp - - 0.02 0.04
neomile corporate advisor... - - - 1.02
neomile growth fund - ser... 1.98 1.98 2.48 1.98
elara india opportunities... 1.22 1.20 1.20 -
eminence global fund pcc-... 1.31 1.31 1.31 -
saint capital fund 1.25 1.19 - -
zinnia global fund pcc - ... 1.20 1.19 - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us
Last Updated on:
Brief about Mukka Proteins
X